Sun Pharma to launch Brillo, a first-in-class oral lipid-lowering drug in India

Bempedoic Acid administered as a 180-mg dose, is approved by the USFDA and European Union for the treatment of hypercholesterolemia

BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca

A total of three targets have been selected for portfolio entry in the collaboration to date, with the potential to generate further future development milestones and sales-based royalty revenues for BenevolentAI

Adroit BioMed launches Fortisil range of skincare products

New report highlights lack of access to assistive technology

WHO and UNICEF call on governments, industry, donors and civil society to fund and prioritize access to assistive products

USFDA approves novel, dual-targeted treatment for type 2 diabetes

In clinical trials, treatment proved more effective than other therapies evaluated

LOTTE to purchase Bristol Myers Squibb manufacturing facility in East Syracuse, New York

East Syracuse site to serve as the LOTTE Center for North America Operations for LOTTE’s biologics contract development and manufacturing organization (CDMO) business

WHO and MPP announce agreement with NIH for Covid-19 health technologies

The licences will allow manufacturers from around the world to work with MPP and C-TAP to make these technologies accessible to people living in low- and middle-income countries

TwistPak: Mixing platform for swine vaccines brings convenience and flexibility

Boehringer Ingelheim continues to innovate to enhance the customer experience and improve animal health and well-being

OvaCis rapid test to detect ovarian cancer gets CE mark

Revolutionary ovarian cancer rapid test available Q4 2022

Boehringer Ingelheim’s signal analytics technology acquired by ArisGlobal

ArisGlobal acquires Boehringer Ingelheim’s Benefit-Risk Analytic System (BRASS), a software solution designed to support causal analysis of drug safety data in a highly regulated environment